Skip to main navigation
Adamis
  • Contact Us
Select Page
  • About
    • Overview
    • Management
    • Board of Directors
  • Customized Medications
  • Products
  • Pipeline
    • Specialty Pharmaceuticals
    • APC – 1000
    • APC – 4000
    • APC – 6000
    • APC – 8000
  • Investors

    Investor Relations

    • Investors
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events and Presentations
    • Email Alerts
  • Careers
    • Partnerships
  • Contact Us

Presentations

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts

Tools

  • Print Page

Presentations

Presentations
Company Presentation 1.4 MB
Events
Adamis Pharmaceuticals Third Quarter 2020 Conference Call
November 9, 2020
Q3 2020 Conference Call 6.3 MB
Adamis Pharmaceuticals Second Quarter 2020 Conference Call
August 20, 2020
Adamis Pharmaceuticals First Quarter 2020 Conference Call
May 18, 2020
Adamis Pharmaceuticals Announces 2019 Financial Results and Business Update
March 30, 2020
Adamis Pharmaceuticals Third Quarter 2019 Conference Call
November 12, 2019
Institute of Human Virology Scientific Meeting
October 4, 2019
Adamis
  • About

  • Management
  • Board of Directors
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in the therapeutic areas of respiratory disease and allergy.
  • Customized Medications

  • Products

  • Pipeline

  • Specialty Pharmaceuticals
    • APC – 6000
    • APC – 8000
  • Metered Dose Inhalers
    • APC – 1000
  • Dry Powder Inhaler Platform
    • APC – 4000
  • Partnerships

Investor Relations

  • Investors
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events and Presentations
  • Email Alerts
  • Careers
  • Partnerships
  • Contact Us

858.997.2400
  • Privacy Statement
  • Terms of Use

2021 Copyright Adamis Pharmaceuticals Corporation